Oncology
Alpha-fetoprotein has more validity in nonviral liver cancer diagnoses
Published in Hepatitis Weekly, August 4th, 2003
"With the widespread use of ultrasonography (US) and computerized tomography (CT), the usefulness of alpha (a)-fetoprotein assay in the diagnosis of hepatocellular carcinoma (HCC) has decreased. The aim of our study was to evaluate the best cut-off value for serum a-fetoprotein to discriminate between liver cirrhosis (LC) and HCC and the factors influencing levels in a Sicilian population. Three hundred and seventy-two patients with LC and 197 with HCC-associated LC were studied," according to a study from Italy.
"The etiology was: HCV in 288 cases (774%) of LC and 147 cases...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2003-08-04)
More Articles from Hepatitis Weekly
- Chronic Hepatitis C
Ribavirin maintenance therapy improves biochemical findings in nonresponders - Hematology
Scientists confirm a link between hepatitis C virus and non-Hodgkin lymphoma - Hepatitis C Therapy
Nucleoside chain terminators face many hurdles for overcoming HCV polymerase - Phytotherapy
Cell culture assays screen for the effects of hepatitis C virus inhibitors - Toxicology
Multiple indices are required when the goal is to define hepatotoxicity - Biomarkers
Plasma P-selectin levels rise in people with chronic liver diseases - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
